Profile
Full Name
Beam Therapeutics Inc.Ticker Symbol
BEAMExchange
NASDAQSector
HealthcareIndustry
BiotechnologyCountry
United StatesIPO
February 6, 2020Indexes
Not includedWebsite
http://beamtx.comEmployees
483Key Details
Price
$16.62(-3.82%)
Market cap
$1.39B(Small cap)
Last Dividend
-
TTM Dividend yield
-
Annual revenue
$63.52M(-83.18% YoY)
Annual EPS
-$4.58(-166.28% YoY)
PE ratio
-
Next earnings date
May 7, 2025Next ex-dividend date
N/ANext split date
N/APrice
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price Performance
Price Range
Capitalization
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Market cap
Shares Outstanding
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Beam Therapeutics doesn't have historical dividend data
Income Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
EPS
Profit
Expenses
EBIT & EBITDA
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Liabilities
Debt
Equity & Capital
Cash Flow Statement
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
CAPEX
Free Cash Flow
Profitability Ratios
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Margins
ROA & ROE
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Analyst ratings
Recent major analysts updates
Apr 7, 25 HC Wainwright & Co.
BuyMar 28, 25 B of A Securities
BuyMar 12, 25 Cantor Fitzgerald
OverweightMar 10, 25 Scotiabank
Sector OutperformMar 10, 25 Jones Trading
BuyMar 10, 25 HC Wainwright & Co.
BuyMar 3, 25 Scotiabank
Sector PerformFeb 28, 25 HC Wainwright & Co.
BuyFeb 27, 25 Guggenheim
BuyFeb 26, 25 RBC Capital
Sector PerformInstitutional Ownership
- What is the ticker symbol for Beam Therapeutics?
- Does Beam Therapeutics pay dividends?
- What sector is Beam Therapeutics in?
- What industry is Beam Therapeutics in?
- What country is Beam Therapeutics based in?
- When did Beam Therapeutics go public?
- Is Beam Therapeutics in the S&P 500?
- Is Beam Therapeutics in the NASDAQ 100?
- Is Beam Therapeutics in the Dow Jones?
- When was Beam Therapeutics's last earnings report?
- When does Beam Therapeutics report earnings?
- Should I buy Beam Therapeutics stock now?
What is the ticker symbol for Beam Therapeutics?
The ticker symbol for Beam Therapeutics is NASDAQ:BEAM
Does Beam Therapeutics pay dividends?
No, Beam Therapeutics does not pay dividends
What sector is Beam Therapeutics in?
Beam Therapeutics is in the Healthcare sector
What industry is Beam Therapeutics in?
Beam Therapeutics is in the Biotechnology industry
What country is Beam Therapeutics based in?
Beam Therapeutics is headquartered in United States
When did Beam Therapeutics go public?
Beam Therapeutics's initial public offering (IPO) was on February 6, 2020
Is Beam Therapeutics in the S&P 500?
No, Beam Therapeutics is not included in the S&P 500 index
Is Beam Therapeutics in the NASDAQ 100?
No, Beam Therapeutics is not included in the NASDAQ 100 index
Is Beam Therapeutics in the Dow Jones?
No, Beam Therapeutics is not included in the Dow Jones index
When was Beam Therapeutics's last earnings report?
Beam Therapeutics's most recent earnings report was on Feb 25, 2025
When does Beam Therapeutics report earnings?
The next expected earnings date for Beam Therapeutics is May 7, 2025
Should I buy Beam Therapeutics stock now?
As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions